Here is an article worth reading: Link: http:
Post# of 416
(Total Views: 539)
Posted On: 02/01/2018 12:26:23 AM
Here is an article worth reading:
Link:
http://www.nasdaqreporter.com/4-biotech-stock...asdaqexel/
4 Biotech Stocks To Watch in 2018 : Endonovo Therapeutics, Inc. (OTCQB:ENDV), Welltower Inc (NYSE:HCN), Geron Corporation (NASDAQ:GERN), and Exelixis, Inc. (NASDAQ:EXEL).
Endonovo Therapeutics, Inc. (OTCQB:ENDV)
Endonovo Therapeutics, Inc. is a commercial-stage developer of non-invasive wearable Electroceuticals™. The Company’s current portfolio of commercial and clinical-stage wearable Electroceuticals™ addresses wound healing, pain, post-surgical edema and Central Nervous System (CNS) Disorders, including traumatic brain injury (TBI), acute concussions, post-concussion syndrome and multiple sclerosis. The Company’s current portfolio of pre-clinical stage Electroceuticals™ addresses chronic kidney disease, liver disease, cardiovascular and peripheral artery disease. The Company’s non-invasive Electroceuticals™ work by delivering electrical stimulation to tissues in order to restore key electrochemical processes that initiate anti-inflammatory and growth factor cascades necessary for healing to occur.
In a recent press release, the Company announced the first commercial sales of SofPulse™, its non-invasive, wearable Electroceutical™ device. SofPulse™ is the Company’s FDA-Cleared Electroceutical™ System for the palliative treatment of post-operative pain and edema in superficial soft tissues. Furthermore, the Company announced it is seeking distribution partners in Europe for SofPulse™, which is CE-Marked for the promotion of wound healing, reduction of pain and post-operative edema.
Full Press Release : https://www.otcmarkets.com/stock/ENDV/news/En...72&b=y
Link:
http://www.nasdaqreporter.com/4-biotech-stock...asdaqexel/
4 Biotech Stocks To Watch in 2018 : Endonovo Therapeutics, Inc. (OTCQB:ENDV), Welltower Inc (NYSE:HCN), Geron Corporation (NASDAQ:GERN), and Exelixis, Inc. (NASDAQ:EXEL).
Endonovo Therapeutics, Inc. (OTCQB:ENDV)
Endonovo Therapeutics, Inc. is a commercial-stage developer of non-invasive wearable Electroceuticals™. The Company’s current portfolio of commercial and clinical-stage wearable Electroceuticals™ addresses wound healing, pain, post-surgical edema and Central Nervous System (CNS) Disorders, including traumatic brain injury (TBI), acute concussions, post-concussion syndrome and multiple sclerosis. The Company’s current portfolio of pre-clinical stage Electroceuticals™ addresses chronic kidney disease, liver disease, cardiovascular and peripheral artery disease. The Company’s non-invasive Electroceuticals™ work by delivering electrical stimulation to tissues in order to restore key electrochemical processes that initiate anti-inflammatory and growth factor cascades necessary for healing to occur.
In a recent press release, the Company announced the first commercial sales of SofPulse™, its non-invasive, wearable Electroceutical™ device. SofPulse™ is the Company’s FDA-Cleared Electroceutical™ System for the palliative treatment of post-operative pain and edema in superficial soft tissues. Furthermore, the Company announced it is seeking distribution partners in Europe for SofPulse™, which is CE-Marked for the promotion of wound healing, reduction of pain and post-operative edema.
Full Press Release : https://www.otcmarkets.com/stock/ENDV/news/En...72&b=y
(0)
(0)Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
WORDS TO LIVE BY:
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.